Seshiru Nakazawa
机构：Gunma University, Dana-Farber Cancer Institute, Gunma University Hospital · ORCID：0000-0001-6218-9396
发表论文 341 篇 · 总被引 1619 次 · h-index 18
代表论文
- Diagnostic Performance of a 4-miRNA Blood Panel for Colorectal Cancer (2026 · Research Square)
- Supplementary Figure 6 from Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors (2026)
- Supplementary Figure 3 from Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors (2026)
- Supplementary Table 3 from Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors (2026)
- Supplementary Figure 13 from Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors (2026)
- Supplementary Table 20 from Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors (2026)